Hypertensive treatment in patients with metabolic syndrome

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The prevalence of obesity, hypertension, and type 2 diabetes mellitus - in other words, the metabolic syndrome - is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on parameters of the metabolic syndrome in addition to glucose metabolism. Here the authors review pertinent clinical studies.

Original languageEnglish (US)
Pages (from-to)95-103
Number of pages9
JournalMetabolic Syndrome and Related Disorders
Volume8
Issue number2
DOIs
StatePublished - Apr 1 2010

Fingerprint

Type 2 Diabetes Mellitus
Antihypertensive Agents
Obesity
Hypertension
Glucose
Therapeutics
Clinical Studies

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Hypertensive treatment in patients with metabolic syndrome. / Siegel, David; Swislocki, Arthur L.

In: Metabolic Syndrome and Related Disorders, Vol. 8, No. 2, 01.04.2010, p. 95-103.

Research output: Contribution to journalArticle

@article{8b946a56e4da4f83a600918e56d83f3a,
title = "Hypertensive treatment in patients with metabolic syndrome",
abstract = "The prevalence of obesity, hypertension, and type 2 diabetes mellitus - in other words, the metabolic syndrome - is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on parameters of the metabolic syndrome in addition to glucose metabolism. Here the authors review pertinent clinical studies.",
author = "David Siegel and Swislocki, {Arthur L}",
year = "2010",
month = "4",
day = "1",
doi = "10.1089/met.2009.0086",
language = "English (US)",
volume = "8",
pages = "95--103",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Hypertensive treatment in patients with metabolic syndrome

AU - Siegel, David

AU - Swislocki, Arthur L

PY - 2010/4/1

Y1 - 2010/4/1

N2 - The prevalence of obesity, hypertension, and type 2 diabetes mellitus - in other words, the metabolic syndrome - is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on parameters of the metabolic syndrome in addition to glucose metabolism. Here the authors review pertinent clinical studies.

AB - The prevalence of obesity, hypertension, and type 2 diabetes mellitus - in other words, the metabolic syndrome - is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on parameters of the metabolic syndrome in addition to glucose metabolism. Here the authors review pertinent clinical studies.

UR - http://www.scopus.com/inward/record.url?scp=77950620589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950620589&partnerID=8YFLogxK

U2 - 10.1089/met.2009.0086

DO - 10.1089/met.2009.0086

M3 - Article

VL - 8

SP - 95

EP - 103

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 2

ER -